Azelaic Acid for Androgenetic Alopecia
There is no good evidence that topical azelaic acid regrows hair in androgenetic alopecia. It is an off-label, mechanism-only use, and it should not replace proven treatments such as minoxidil or finasteride.
Why this grade7-layer evidence engine
This claim earns a D (Counter-Evidence) grade because no high-quality trial shows azelaic acid working on its own for male- or female-pattern hair loss. The only verifiable human study, a minoxidil 'high extra' combination RCT (PMID 23163069), merely lists azelaic acid as one of several ingredients, so its independent effect cannot be separated from minoxidil, and the paper carries no abstract to quantify any benefit.
The supporting rationale is mechanistic rather than clinical. An evidence-based review (PMID 26355614) notes that azelaic acid inhibits follicular keratinization and may block 5-alpha-reductase in vitro, which marketers stretch into a DHT-lowering hair-growth claim. The same review does not establish it as a standalone treatment for androgenetic alopecia, and the theoretical DHT effect has never been confirmed by a quality human trial.
Regulators and clinics reinforce the verdict. The FDA, NHS/NICE and Taiwan's TFDA approve azelaic acid only for acne and rosacea, never hair loss, and EFSA issues no food health claim. Major clinical sources (Mayo, Cleveland Clinic, Harvard) do not mention it for hair loss at all. The evidence-based first-line options remain topical minoxidil and oral finasteride.
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditable▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.43
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 無高階證據可裁決
- tier_strict_requirement_check — | C→D 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status